Exploring the structural activity relationship of the Osimertinib: A covalent inhibitor of double mutant EGFRL858R/T790M tyrosine kinase for the treatment of Non-Small Cell Lung Cancer (NSCLC)
Article in Bioorganic & Medicinal Chemistry (June 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in Bioorganic & Medicinal Chemistry (June 2024)
Preprint in bioRxiv (March 2024)
Article in Current Oncology (January 2024)